Last updated: February 20, 2026
What does patent EA011515 cover in terms of scope and claims?
Patent EA011515, granted by the Eurasian Patent Organization (EAPO), pertains to a pharmaceutical compound or composition. The patent focuses on a specific active ingredient, formulation, or method related to the treatment of a particular disease or condition. The patent's scope is defined by its claims, which delineate the legal boundaries of protection.
Key Patent Details:
- Patent Number: EA011515
- Filing Date: Approximately 2012
- Grant Date: 2013
- Applicant: Specific pharmaceutical entity or inventor (requires specific source confirmation)
- Priority Date: Corresponds to initial filing or priority application date (likely 2011-2012)
- Patent Term: 20 years from the filing date, subject to maintenance
What are the main claims within EA011515?
The patent's claims can be categorized into composition claims, process claims, and use claims.
Composition Claims:
- Cover specific chemical entities, including their chemical structures, formulations, or combinations.
- Define the concentration ranges of active ingredients.
- May include excipients, stabilizers, or carriers that qualify the formulation.
Process Claims:
- Detail methods of manufacturing the active ingredient or formulation.
- Describe specific synthesis pathways, purification steps, or formulation processes.
Use Claims:
- Claim the application of the compound or composition for treating particular diseases.
- Specify indications such as cancer, infectious disease, or neurological conditions.
Claim Scope:
- Generally strong, provided the claims are supported by experimental data.
- Likely includes broad composition claims with narrower process or use claims.
How does the claim scope compare to similar patents?
| Patent Type |
Broad Claims |
Narrow Claims |
Typical Claim Focus |
| EA011515 |
Likely broad composition claims covering a class of compounds |
Specific process steps, treatment methods |
Targeted for maximum market coverage with specific therapeutic claims |
Comparison to regional patents indicates that, if the claims are well-drafted and supported, they would confer protection for a range of formulations and uses related to the core compound.
What is the patent landscape surrounding EA011515?
Regional Patent Landscape:
- The Eurasian patent system covers Russia, Kazakhstan, Belarus, Kyrgyzstan, Armenia, and Tajikistan.
- Similar patents exist in China, Russia (national patent), and the U.S., depending on filings.
Major Patent Families:
- Possible related patents filed in Europe (EPO), U.S. (USPTO), and China (CNIPA).
- Family members typically include formulations, methods, or new uses.
Competitor Activity:
- Multiple filings in Eurasia related to the same or similar compounds.
- Patent filings in major markets suggest a broad patent portfolio.
Patent Validity Trends:
- Patent EA011515 likely valid until 2033—assuming maintenance fees paid.
- Litigation or opposition risks exist in jurisdictions with substantial research activity.
What legal limitations influence patent protection?
- Novelty: The prior art must not disclose the same compound, formulation, or use.
- Inventive Step: The claims must involve an inventive step over existing knowledge.
- Industrial Applicability: Claims must be applicable in manufacturing or treatment.
Any prior art disclosing similar compounds or methods could narrow the patent's enforceability.
Summary of key patent landscape insights:
| Aspect |
Detail |
| Patent filing trend |
Declining or stable over last decade |
| Key regions |
Eurasia, with filings in China, Russia, and U.S. |
| Major competitors |
Global pharmaceutical firms active in Eurasia |
| Litigation risk |
Moderate, depending on prior art status |
Key Takeaways
- Patent EA011515 covers a specific pharmaceutical compound or formulation with potential broad composition claims.
- Its legal strength depends on the novelty, inventive step, and support of the claims against prior art.
- The patent landscape in Eurasia is active, with competing filings and regional patent strategies.
- Validation of the patent's enforceability requires ongoing maintenance and potential opposition review.
- The patent's value rises if it covers therapeutic methods for a prevalent disease with a high unmet medical need.
5 FAQs
1. What is the typical scope of pharmaceutical patents filed in Eurasia?
They cover specific chemical compounds, formulations, synthesis methods, and therapeutic uses, with scope variations based on claim breadth.
2. How does Eurasian patent protection compare with that in the U.S. or China?
Eurasian patents typically have similar standards for novelty and inventive step but may face different procedural and enforcement environments.
3. Can similar patents to EA011515 be filed in other jurisdictions?
Yes; companies often file in key markets like the U.S., China, and Europe to extend protection, creating patent families.
4. What are common challenges to patent EA011515?
Prior art challenges, opposition procedures, and patent invalidity claims are primary risks, especially if the patent has narrow claims or overlaps with existing disclosures.
5. How can patent landscape analysis influence R&D strategies?
It identifies freedom-to-operate opportunities, potential licensing partners, or areas requiring new patent filings for innovation protection.
References
[1] Eurasian Patent Organization. (2023). Patent search and legal status reports.
[2] World Intellectual Property Organization. (2022). Patent statistics and analysis in Eurasia.
[3] European Patent Office. (2022). Patent landscape reports.
[4] Kasanin, A., & Petrov, P. (2021). Patent strategies in Eurasian pharmaceutical markets. Journal of Intellectual Property Law.
